These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36119438)

  • 1. Mast Cell Sarcoma of the Retroperitoneum With Concurrent Systemic Mastocytosis and an Undisclosed Associated Hematologic Neoplasm: A Case Report.
    Chen I; Liao JB; Lin JC; Hsieh PP; Hsieh MY
    Clin Pathol; 2022; 15():2632010X221123539. PubMed ID: 36119438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic mastocytosis with myeloid sarcoma and B-CLL: molecular and clonal heterogeneity in a rare case of SM-AHN with review of literature.
    Decruyenaere P; Mazure D; Moors I; Van Dorpe J; Van der Linden M; Denys B; Hofmans M; Offner F
    Acta Clin Belg; 2023 Feb; 78(1):58-66. PubMed ID: 35098906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's lymphoma is a rare form of clonal haematological non-mast cell disease in systemic mastocytosis.
    Gasljevic G; Grcar-Kuzmanov B; Grosel A; Sever M; Gazic B; Kloboves-Prevodnik V
    Diagn Pathol; 2015 Mar; 10():5. PubMed ID: 25881198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic Mastocytosis: Advances in Diagnosis and Current Management.
    Pullarkat ST; Wu W; Pullarkat V
    Cancer Treat Res; 2021; 181():167-178. PubMed ID: 34626361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis and classification of mast cell proliferative disorders: delineation from immunologic diseases and non-mast cell hematopoietic neoplasms.
    Valent P; Sperr WR; Schwartz LB; Horny HP
    J Allergy Clin Immunol; 2004 Jul; 114(1):3-11; quiz 12. PubMed ID: 15241337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: clinical significance and comparison of chomosomal abnormalities in SM and AHNMD components.
    Wang SA; Hutchinson L; Tang G; Chen SS; Miron PM; Huh YO; Jones DM; Bueso-Ramos C; Verstovsek S; Medeiros LJ; Miranda RN
    Am J Hematol; 2013 Mar; 88(3):219-24. PubMed ID: 23440662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful Imatinib Treatment for Systemic Mastocytosis Associated With Myelodysplastic/Myeloproliferative Neoplasm: Report of a Case and Literature Review.
    Barozzi E; Bucelli C; Grifoni FI; Gianelli U; Iurlo A; Cattaneo D
    Front Oncol; 2021; 11():819097. PubMed ID: 35096623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on Mastocytosis (Part 2): Categories, Prognosis, and Treatment.
    Azaña JM; Torrelo A; Matito A
    Actas Dermosifiliogr; 2016; 107(1):15-22. PubMed ID: 26525106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision Medicine in Systemic Mastocytosis.
    Nicolosi M; Patriarca A; Andorno A; Mahmoud AM; Gennari A; Boldorini R; Gaidano G; Crisà E
    Medicina (Kaunas); 2021 Oct; 57(11):. PubMed ID: 34833353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic Mastocytosis with Smoldering Multiple Myeloma: Report of a Case.
    Ghanem S; Garcia G; Ying L; Hurford M; Odaimi M
    Case Rep Oncol Med; 2016; 2016():3161768. PubMed ID: 27293930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Mastocytosis with Associated Hematological Neoplasms. Diagnostic features and unique response pattern to tyrosine kinase inhibitors and allo-bone marrow transplantation therapy.
    Hernández Alconchel I; González de Villambrosía S; Insunza Gaminde A; Montes Moreno S
    Rev Esp Patol; 2023; 56(3):180-185. PubMed ID: 37419556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An adult patient with systemic mastocytosis and B-acute lymphoblastic leukemia.
    Iliakis T; Rougkala N; Diamantopoulos PT; Papadopoulou V; Kalala F; Zervakis K; Giannakopoulou N; Chatzinikolaou P; Levidou G; Lakiotaki E; Korkolopoulou P; Patsouris E; Variami E; Viniou NA
    Case Rep Med; 2014; 2014():526129. PubMed ID: 25431599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic abnormalities in systemic mastocytosis: WHO subcategory-specific incidence and prognostic impact among 348 informative cases.
    Shah S; Pardanani A; Elala YC; Lasho TL; Patnaik MM; Reichard KK; Hanson CA; Ketterling RP; Tefferi A
    Am J Hematol; 2018 Dec; 93(12):1461-1466. PubMed ID: 30152525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FDG-PET/CT findings in systemic mastocytosis: a French multicentre study.
    Djelbani-Ahmed S; Chandesris MO; Mekinian A; Canioni D; Brouzes C; Hanssens K; Pop G; Durieu I; Durupt S; Grosbois B; Besnard S; Tournilhac O; Beyne-Rauzy O; Agapé P; Delmer A; Ranta D; Jeandel PY; Georgin-Lavialle S; Frenzel L; Damaj G; Eder V; Lortholary O; Hermine O; Fain O; Soussan M
    Eur J Nucl Med Mol Imaging; 2015 Dec; 42(13):2013-20. PubMed ID: 26140850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User's Guide for Daily Clinical Practice.
    Valent P; Hartmann K; Schwaab J; Alvarez-Twose I; Brockow K; Bonadonna P; Hermine O; Niedoszytko M; Carter MC; Hoermann G; Sperr WR; Butterfield JH; Ustun C; Zanotti R; Radia DH; Castells M; Triggiani M; Schwartz LB; Orfao A; George TI; Sotlar K; Gotlib J; Reiter A; Horny HP; Arock M; Akin C; Metcalfe DD
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1999-2012.e6. PubMed ID: 35342031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case report of systemic mastocytosis associated with multiple hematologic non-mast cell lineage diseases.
    Grifoni FI; Sciumè M; Pravettoni V; Ulivieri FM; Muratori S; Fracchiolla NS; Tagliaferri E; Gianelli U; Migliorini AC; Cro L; Pacilli A; Mannelli F; Baldini L
    Hematol Oncol; 2019 Apr; 37(2):205-211. PubMed ID: 30849188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group.
    Sotlar K; George TI; Kluin P; Reiter A; Schwaab J; Panse J; Brockow K; Hartmann K; Sperr WR; Kristensen T; Nedoszytko B; Carter M; Bonadonna P; Lyons JJ; Kluin-Nelemans HC; Hermine O; Akin C; Broesby-Olsen S; Hoermann G; Triggiani M; Butterfield JH; Jawhar M; Gotlib J; Metcalfe DD; Orfao A; Arock M; Valent P; Horny HP
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1986-1998.e2. PubMed ID: 35724949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Outcomes of Adults with Systemic Mastocytosis: A 15-Year Multidisciplinary Experience.
    Ungerstedt J; Ljung C; Klimkowska M; Gülen T
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mastocytosis onset in a patient with treated hairy cell leukemia: Just a coincidence?
    Boilève A; Contejean A; Barreau S; Sourdeau É; Friedrich C; Kosmider O; Burroni B; Dupin N; Lheure C; Rossignol J; Bouscary D; Grignano É
    Blood Cells Mol Dis; 2020 Mar; 81():102392. PubMed ID: 31794934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.